A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy

Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosi...

Full description

Saved in:
Bibliographic Details
Published inJournal of pathology and translational medicine Vol. 54; no. 3; pp. 228 - 236
Main Authors Lee, Kyoungbun, Jung, Eun Sun, Yu, Eunsil, Kang, Yun Kyung, Cho, Mee-Yon, Kim, Joon Mee, Moon, Woo Sung, Jeong, Jin Sook, Park, Cheol Keun, Park, Jae-Bok, Kang, Dae Young, Sohn, Jin Hee, Jin, So-Young
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Pathologists, Korean Society for Cytopathology 01.05.2020
The Korean Society of Pathologists and the Korean Society for Cytopathology
Korean Society of Pathologists & the Korean Society for Cytopathology
대한병리학회
Subjects
Online AccessGet full text
ISSN2383-7837
2383-7845
2383-7845
DOI10.4132/jptm.2020.03.07

Cover

Abstract Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis. Thirteen pathologists blindly assessed 12 histological factors and final histological diagnoses ('not-NASH,' 'borderline,' and 'NASH') of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system. Inter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation ( ≥ 2 foci/ × 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ = 0.52-0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (× 2) and minor factors may be used for the practical diagnosis of NASH. A scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD.
AbstractList Background Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis. Methods Thirteen pathologists blindly assessed 12 histological factors and final histological diagnoses (‘not-NASH,’ ‘borderline,’ and ‘NASH’) of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system. Results Inter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation (≥ 2 foci/ × 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ = 0.52–0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (× 2) and minor factors may be used for the practical diagnosis of NASH. Conclusions A scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD.
Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis. Thirteen pathologists blindly assessed 12 histological factors and final histological diagnoses ('not-NASH,' 'borderline,' and 'NASH') of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system. Inter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation ( ≥ 2 foci/ × 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ = 0.52-0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (× 2) and minor factors may be used for the practical diagnosis of NASH. A scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD.
Background: Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis. Methods: Thirteen pathologists blindly assessed 12 histological factors and final histological diagnoses ('not-NASH,' 'borderline,' and 'NASH') of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system. Results: Inter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation ( > 2 foci/ x 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ=0.52-0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (x 2) and minor factors may be used for the practical diagnosis of NASH. Conclusions: A scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD.
Background: Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis. Methods: Thirteen pathologists blindly assessed 12 histological factors and final histological diagnoses (‘not-NASH,’ ‘borderline,’ and ‘NASH’) of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system. Results: Inter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation ( ≥ 2 foci/ × 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ = 0.52–0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (× 2) and minor factors may be used for the practical diagnosis of NASH. Conclusions: A scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD. KCI Citation Count: 0
Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis.BACKGROUNDLiver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model for diagnosis.Thirteen pathologists blindly assessed 12 histological factors and final histological diagnoses ('not-NASH,' 'borderline,' and 'NASH') of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system.METHODSThirteen pathologists blindly assessed 12 histological factors and final histological diagnoses ('not-NASH,' 'borderline,' and 'NASH') of 31 liver biopsies that were diagnosed as non-alcoholic fatty liver disease (NAFLD) or NASH before and after consensus. The main histological parameters to diagnose NASH were selected based on histological diagnoses and the diagnostic accuracy and agreement of 12 scoring models were compared for final diagnosis and the NAFLD Activity Score (NAS) system.Inter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation ( ≥ 2 foci/ × 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ = 0.52-0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (× 2) and minor factors may be used for the practical diagnosis of NASH.RESULTSInter-observer agreement of final diagnosis was fair (κ = 0.25) before consensus and slightly improved after consensus (κ = 0.33). Steatosis at more than 5% was the essential parameter for diagnosis. Major diagnostic factors for diagnosis were fibrosis except 1C grade and presence of ballooned cells. Minor diagnostic factors were lobular inflammation ( ≥ 2 foci/ × 200 field), microgranuloma, and glycogenated nuclei. All 12 models showed higher inter-observer agreement rates than NAS and post-consensus diagnosis (κ = 0.52-0.69 vs. 0.33). Considering the reproducibility of factors and practicability of the model, summation of the scores of major (× 2) and minor factors may be used for the practical diagnosis of NASH.A scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD.CONCLUSIONSA scoring system for the diagnosis of NAFLD would be helpful as guidelines for pathologists and clinicians by improving the reproducibility of histological diagnosis of NAFLD.
Author Jeong, Jin Sook
Kang, Dae Young
Jin, So-Young
Kang, Yun Kyung
Yu, Eunsil
Kim, Joon Mee
Park, Jae-Bok
Jung, Eun Sun
Park, Cheol Keun
Moon, Woo Sung
Sohn, Jin Hee
Cho, Mee-Yon
Lee, Kyoungbun
Author_xml – sequence: 1
  givenname: Kyoungbun
  surname: Lee
  fullname: Lee, Kyoungbun
– sequence: 2
  givenname: Eun Sun
  surname: Jung
  fullname: Jung, Eun Sun
– sequence: 3
  givenname: Eunsil
  surname: Yu
  fullname: Yu, Eunsil
– sequence: 4
  givenname: Yun Kyung
  surname: Kang
  fullname: Kang, Yun Kyung
– sequence: 5
  givenname: Mee-Yon
  surname: Cho
  fullname: Cho, Mee-Yon
– sequence: 6
  givenname: Joon Mee
  surname: Kim
  fullname: Kim, Joon Mee
– sequence: 7
  givenname: Woo Sung
  surname: Moon
  fullname: Moon, Woo Sung
– sequence: 8
  givenname: Jin Sook
  surname: Jeong
  fullname: Jeong, Jin Sook
– sequence: 9
  givenname: Cheol Keun
  surname: Park
  fullname: Park, Cheol Keun
– sequence: 10
  givenname: Jae-Bok
  surname: Park
  fullname: Park, Jae-Bok
– sequence: 11
  givenname: Dae Young
  surname: Kang
  fullname: Kang, Dae Young
– sequence: 12
  givenname: Jin Hee
  surname: Sohn
  fullname: Sohn, Jin Hee
– sequence: 13
  givenname: So-Young
  surname: Jin
  fullname: Jin, So-Young
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32460476$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002587082$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFks1vFCEYxiemxtbaszcziRd7mC1fw8fFZNNY3aSJiWnPhGFgly0zjMDW7H8vu1s3tgc9EAj8nud94eFtdTKG0VTVewhmBGJ0tZ7yMEMAgRnAM8BeVWcIc9wwTtqT4xqz0-oipTUAAJIWUyLeVKcYEQoIo2fV_bxOOkQ3Luu0TdkMtQ2xzitT904tx5BcqoOtS-VGeR1WwTtdF07lsDKTyi4XwMYw1N49mlh3Lkxp-656bZVP5uJpPq_ub77cXX9rbr9_XVzPbxvdcpYb2rY9N9CyMnqjSSegERpqBTpFe44V6jCnWJtOWGu1aCEkFHWAAgZ71lt8Xl0efMdo5YN2Mii3n5dBPkQ5_3G3kAJRBoko7OLA9kGt5RTdoOJ2L9hvhLiUKmanvZGlhCGAM020IEQUMee4w4AhwxESpniBg9dmnNT2l_L-aAiB3IUjd-HIXTgSYAlYkXw-SKZNN5hemzFH5Z_18fxkdKtyjUfJUIsFhcXg05NBDD83JmU5uKSN92o0YZMkIoC1nCCOCvrxBboOmziWJHZUyzkXlBfqw98dHVv58zkK0B4AHUNK0VipXS6Rh12Dzv_jqlcvdP97nN_0I98V
CitedBy_id crossref_primary_10_1002_oby_24018
crossref_primary_10_1002_mnfr_202400227
crossref_primary_10_1016_j_gastrohep_2021_12_004
crossref_primary_10_1016_j_tox_2024_154020
crossref_primary_10_1038_s41598_024_80119_5
crossref_primary_10_1016_j_gastre_2021_12_005
crossref_primary_10_1016_j_jconrel_2024_07_011
crossref_primary_10_1111_iep_12519
Cites_doi 10.1002/hep.25889
10.1053/j.gastro.2015.04.043
10.1016/j.jhep.2012.07.027
10.1002/hep.27173
10.4132/jptm.2016.03.01
10.1111/apm.12742
10.1111/j.1572-0241.1999.01377.x
10.1002/hep.20701
10.1111/j.1365-2036.2011.04695.x
ContentType Journal Article
Copyright 2020. This work is published under NOCC (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 The Korean Society of Pathologists/The Korean Society for Cytopathology 2020
Copyright_xml – notice: 2020. This work is published under NOCC (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 The Korean Society of Pathologists/The Korean Society for Cytopathology 2020
DBID AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
BVBZV
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ADTOC
UNPAY
DOA
ACYCR
DOI 10.4132/jptm.2020.03.07
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
East & South Asia Database
ProQuest One Community College
ProQuest Central
ProQuest Central Student
Research Library Prep
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
East & South Asia Database
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
Publicly Available Content Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2383-7845
EndPage 236
ExternalDocumentID oai_kci_go_kr_ARTI_9267149
oai_doaj_org_article_2b0e4087c4c9449493883b3072e8229e
10.4132/jptm.2020.03.07
PMC7253961
32460476
10_4132_jptm_2020_03_07
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID 5-W
8G5
8JR
AAYXX
ABUWG
ACYCR
ADBBV
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVBZV
CCPQU
CITATION
DIK
DWQXO
EF.
GNUQQ
GROUPED_DOAJ
GUQSH
HYE
KQ8
M2O
M48
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RNS
RPM
ADRAZ
IPNFZ
NPM
RIG
3V.
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c587t-655d8e1f7e1fdec4b91e9c1ca0ba6d83a2b3863ceb9fffc9511462b06071d7df3
IEDL.DBID M48
ISSN 2383-7837
2383-7845
IngestDate Sun Mar 09 07:51:33 EDT 2025
Fri Oct 03 12:44:00 EDT 2025
Sun Oct 26 04:13:53 EDT 2025
Tue Sep 30 16:31:57 EDT 2025
Thu Sep 04 18:59:14 EDT 2025
Sun Sep 07 03:39:06 EDT 2025
Mon Jul 21 05:49:27 EDT 2025
Thu Apr 24 23:03:30 EDT 2025
Wed Oct 01 04:01:25 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis
Biopsy
Consensus
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c587t-655d8e1f7e1fdec4b91e9c1ca0ba6d83a2b3863ceb9fffc9511462b06071d7df3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4735-3853
0000-0003-1355-4187
0000-0002-2075-4665
0000-0002-4311-4118
0000-0001-7689-0386
0000-0002-1841-2316
0000-0001-6474-9772
0000-0002-9900-8322
0000-0001-7951-9865
0000-0002-8451-939X
0000-0001-5474-9744
0000-0002-7955-4211
0000-0001-8427-3003
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4132/jptm.2020.03.07
PMID 32460476
PQID 2405888968
PQPubID 1146335
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9267149
doaj_primary_oai_doaj_org_article_2b0e4087c4c9449493883b3072e8229e
unpaywall_primary_10_4132_jptm_2020_03_07
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7253961
proquest_miscellaneous_2407584282
proquest_journals_2405888968
pubmed_primary_32460476
crossref_citationtrail_10_4132_jptm_2020_03_07
crossref_primary_10_4132_jptm_2020_03_07
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-01
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
– name: Seoul
PublicationTitle Journal of pathology and translational medicine
PublicationTitleAlternate J Pathol Transl Med
PublicationYear 2020
Publisher Korean Society of Pathologists, Korean Society for Cytopathology
The Korean Society of Pathologists and the Korean Society for Cytopathology
Korean Society of Pathologists & the Korean Society for Cytopathology
대한병리학회
Publisher_xml – name: Korean Society of Pathologists, Korean Society for Cytopathology
– name: The Korean Society of Pathologists and the Korean Society for Cytopathology
– name: Korean Society of Pathologists & the Korean Society for Cytopathology
– name: 대한병리학회
References ref13
ref12
ref11
ref2
ref1
Randolph (ref8)
Randolph (ref7)
ref4
ref3
Ludwig (ref9) 1980
ref6
ref5
Pournik (ref10) 2014
References_xml – volume-title: Free-marginal multirater kappa (multirater κfree): an alternative to Fleiss fixed-marginal multirater kappa
  ident: ref7
– ident: ref4
  doi: 10.1002/hep.25889
– ident: ref13
  doi: 10.1053/j.gastro.2015.04.043
– ident: ref8
– ident: ref5
  doi: 10.1016/j.jhep.2012.07.027
– ident: ref3
  doi: 10.1002/hep.27173
– ident: ref6
  doi: 10.4132/jptm.2016.03.01
– start-page: 434
  volume-title: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
  year: 1980
  ident: ref9
– ident: ref12
  doi: 10.1111/apm.12742
– ident: ref1
  doi: 10.1111/j.1572-0241.1999.01377.x
– ident: ref2
  doi: 10.1002/hep.20701
– start-page: e15167
  volume-title: Inter-observer and intraobserver agreement in pathological evaluation of non-alcoholic fatty liver disease suspected liver biopsies
  year: 2014
  ident: ref10
– ident: ref11
  doi: 10.1111/j.1365-2036.2011.04695.x
SSID ssj0001453649
Score 2.2230177
Snippet Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve...
Background: Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to...
Background Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to...
SourceID nrf
doaj
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 228
SubjectTerms Accuracy
Alcohol
Biopsy
consensus
Inflammation
Liver diseases
Medical research
Metabolism
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
Original
Regression analysis
Researchers
병리학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQL3BBIL4CBRnEAQ6h2fgzx4KoCgdOrNSb5U8aukpWu1mh_ntmnDTaFaBeOEQrJU6UPI_H72Unz4S8jUkr74IoVUoc31ZpzIOi5IrzYDUIjpDdPr_J8yX_eiEu9pb6wpqw0R54BO6kdlXkFVyQ-4ajlQrTmjmIzDqiV3nE7FvpZk9M5bcrXDCZuS9MSaxUIMNGXx_I2fXJz_WAH6HXVfY3VQdTUnbuh4mm26S_kc4_ayfv7rq1vf5lV6u9iensAbk_MUp6Oj7JQ3Indo_I8pRufa6to6NXMwVySoHs0TDW1rVb2icK2r-04yK5rafY4UN_GbHIeoAG-OkJXWHhBnVtv95ePybLs8_fP52X0woKpRdaDaUUIui4SAq2ED13zSI2fuFt5awMmtnaMS2Zj65JKXlgW5A4AXE0nQsqJPaEHMGdxGeEMhtAzerkYMxywaXljZXA3RpICHVMdUE-3IBo_GQvjqtcrAzIDETdIOoGUTcVM5UqyLv5hPXorPHvph-xV-ZmaImdd0CgmClQzG2BUpA30Kfmyrf5fPz90ZurjQHh8MU0tVQgFgtyfNPlZhrMWwOkR2itG6kL8no-DMMQ_1uxXex3uQ0oL9ByAMTTMULm2wXOKiuuZEHUQewcPM_hka69zFbfqhaskYuCvJ-j7Dawnv8PsF6Qe3jFsbLzmBwNm118CexrcK_yQPsNLYopDQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELbK9gAXVMQrUJBBHOAQmnUcOzkg1KJWhcMKIVbqzXL8aNOukrCbVdV_z4yTbFnxOkSRkolkj-fpjL8h5I3zuTSlzWLpPcfdqhztYBZzybnVOSQcNqB9zsTpnH85y852yGw8C4NllaNNDIbaNgb3yA_A82SQrRUi_9j-iLFrFP5dHVto6KG1gv0QIMbukF2GyFgTsnt0PPv67XbXhWepCDExuKo0lpCe9Xg_YMvZwWXb4eF0lgTcU7nlqgKiPzigeun_FIz-XlN5d123-uZaLxa_OKyTPXJ_iDTpYS8aD8iOqx-S-SFdmVBzR3sMZwpBK4UgkNq-5q5a0cbTuqlj3TfPrQxFQeiaC4fF1x0Q4JEUusCCDlpWTbu6eUTmJ8ffP53GQ2eF2GS57GKRZTZ3Uy_hss7wspi6wkyNTkotbJ5qVqa5SI0rC--9gSgMDCorEwSjs9L69DGZwEjcU0JTbSHLzX0JuswzLjQvtICYrgBDwZxnEXk_MlGZAXYcu18sFKQfyHWFXFfIdZWkKpERebv5oO0RN_5OeoSrsiFDqOzwoFmeq0HzFAzb8QQkkpuCIxYPjDYtwbQxh2D3LiKvYU3VlanC93g_b9TVUkFC8VkVTEhIIiOyPy65GpR8pW5FMiKvNq9BPfGfi65dsw40kJFBjgeMeNJLyGa4EMuKhEsREbklO1vz2X5TVxcBAlyyLC3ENCLvNlL2P2Y9-_cUnpN7SNvXcu6TSbdcuxcQb3Xly0GJfgKAfCja
  priority: 102
  providerName: ProQuest
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6V9AAXHuJlWtCCOMDBqWPvy8eAqAqHigOR2tNqnzSNa1uJI9T-embXTkR4CMHBsmWPrd2d2dlv7PE3CL12XnCjLU259yS8rRLBD9KUcEKsEhBw2Mj2ecpOZuTTGT3bQ2LzL0xIq7wMxXibqruKX_LXbdUoe9Raf3TZdlegVgh4QhIQH8O5W2ifUUDhI7Q_O_08PY-15ESRchHpModjQntWH_DYeXzKODwlspvynQUp8vbDMlMv_e8g56-Zk7fXdauuv6mq-mFZOr6Hzjcd6rNRFuN1p8fm5ieux__p8X10d8CqeNob1wO05-qHaDbFKxOz9nDPAo0B9mKAkdj2WXvzFW48rps6VX353bnBwZS65sKF9O0OBMJPLbgKKSFYz5t2df0IzY4_fHl_kg61GVJDBe9SRqkVbuI5bNYZosuJK83EqEwrZkWhcl0IVhinS--9ARwHLjnXWaCzs9z64jEaQUvcU4QLZSFOFl6DNyCUMEVKxQAVluBqcufzBI03CpJmIC4P9TMqCQFM0KgMoyTDKMmskBlP0JvtDW3P2fFn0XdB41uxQLYdT4Ae5DB3JTTbkQxsmpiSBDYfaG2hwTnmLtDluwS9AnuRCzOP94f910YulhJCko-yzBmHMDRBhxtzkoObWEmAU1QIUTKRoJfbyzDBw1cbVbtmHWUgpoMoEQbiSW992-YCGmYZ4SxBfMcud_qze6WeX0QScZ7TomSTBL3dWvDfBuvZP8geoDu92YbU0EM06pZr9xzgW6dfDDP1OxRPQ1E
  priority: 102
  providerName: Unpaywall
Title A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
URI https://www.ncbi.nlm.nih.gov/pubmed/32460476
https://www.proquest.com/docview/2405888968
https://www.proquest.com/docview/2407584282
https://pubmed.ncbi.nlm.nih.gov/PMC7253961
https://www.jpatholtm.org/upload/pdf/jptm-2020-03-07.pdf
https://doaj.org/article/2b0e4087c4c9449493883b3072e8229e
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002587082
UnpaywallVersion publishedVersion
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Pathology and Translational Medicine, 2020, 54(3), , pp.228-236
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: KQ8
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: DOA
  dateStart: 19850101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: DIK
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: 5-W
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: RPM
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: East & South Asia Database
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: BVBZV
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eastsouthasia
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2383-7845
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: BENPR
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2383-7845
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0001453649
  issn: 2383-7837
  databaseCode: M48
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELZg9wAXBOIVWCqDOMAhJU0c2zmhLtrVgkS1QkRaTpbj2Lthq6S0qaD_nhknDVQUwaGqlNiVM57HN-7kG0JeWieFKco0FM4xPK2S6AfTkAnGSi0h4Sg92-eMn-Xsw0V68asdUC_A1d7UDvtJ5cv5-Me3zVsweMCvY3DB8ZuvixbfKY8jT1cqbpJDCFMZ9nH42GN9f-DC0oR7OAxRKgkFZGYd1c--39iJUp7MH2JPvXT7cOif5ZS31vVCb77r-fy3WHV6l9zpQSaddlpxj9yw9X2ST-nK-HI72tE3U8CrFPAfLbtyu2pFG0frpg511ze3MhR1oG2uLNZdtzAA30ahc6zloEXVLFabByQ_Pfn87izsmyqEJpWiDXmaltJOnIBPaQ0rsonNzMToqNC8lImOi0TyxNgic84ZAGDgS-MiQh66UpQueUgOYCX2MaGJLiHBla4AM2Yp45plmgOcy8BHxNbFARlvhahMzziOjS_mCjIPlLpCqSuUuooSFYmAvBomLDqyjb8PPcZdGYYhS7a_0CwvVW90CpZtWQTKyEzGkIYHVpsU4NViizz3NiAvYE_Vtan8fPy-bNT1UkEu8V5lMReQPwbkaLvlaqueChQslVJmXAbk-XAbLBP_btG1bdZ-DCRjkN6BIB51GjIsF2Asj5jgARE7urPzPLt36urKs3-LOE0yPgnI60HL_iWsJ__znE_JbZzRFXMekYN2ubbPAHC1xYgcHp_Mzj-N_IHFyJsVXMtn59MvPwFTgSvK
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfG9jBe0BBfYQMMAgkewtLEsZOHCW2wqWWjQmiV9mYcf2xlVVLaVFP_Of427py0o-LraQ9VpMaOnPP57n7O-XeEvLQuE7owaSicY7hblaEdTEMmGDMqA8BhPNtnn3cH7ONZerZGfizOwmBa5cImekNtKo175LvgeVJAaznP3o2_h1g1Cr-uLkpoqLa0gtnzFGPtwY5jO78CCDfd632A-X4Vx0eHp--7YVtlINRpJuqQp6nJbMcJ-BmrWZF3bK47WkWF4iZLVFwkGU-0LXLnnIaIBIxLXERIzGaEcQk89xbZYAnLAfxtHBz2P3-53uVhacJ9DA6uMQkFwMGGXwh8R7z7bVzjYfg48jyrYsU1-goC4PDKiftT8Pt7DufmrByr-ZUajX5xkEdb5E4b2dL9RhXvkjVb3iODfTrVPsePNpzRFIJkCkEnNU2O33BKK0fLqgxVU6x3qCkqXl1dWEz2rqEBHoGhI0wgocWwGk_n98ngRmT8gKzDSOwjQhNlAFVnrgDbwVLGFcsVhxgyB8MUWxcH5O1CiFK3NOdYbWMkAe6g1CVKXaLUZZTISATk9bLDuGH4-HvTA5yVZTOk5vZ_VJNz2a50CcO2LIIVwHTOkPsHRpsUYEpji-T6NiAvYE7lpR76_ng9r-TlRAKA6ck85gJAa0B2FlMuW6MylddLICDPl7fBHOA3HlXaaubbAAIETAmCeNhoyHK4EDvziAkeELGiOyvvs3qnHF54ynERp0nOOwF5s9Sy_wnr8b9f4RnZ7J5-OpEnvf7xNrmN_Zo80h2yXk9m9gnEenXxtF1QlHy96TX8EyQIZ4w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGJwEvA8RXxgCDQIKHtGns2MkDQiujWhmaeKDTxItJHHsrrZLSpprKn8a_wj_DXT46yufTHnioIjV2ZDt3v7tzzr8j5ImxodRJGrjSWo67VSHiYOByyXkahxBwpCXb56HYH_I3x8HxBvnanIXBtMoGE0ugTnONe-QdsDwBRGuRCDu2Tot4t9d_Of3sYgUp_NLalNOoROTALM8gfJu_GOzBu37q-_3X71_tu3WFAVcHoSxcEQRpaLpWwi81midR10S6q2MviUUasthPWCiYNklkrdXgjQCw-ImHpGypTC2D514im6EAF7VFNntHvQ9H5zs8PGCi9L_BLDJXQihYcQuB3fA7n6YFHoT3vZJjVa6ZxbJ6ABi7bGZ_5_j-mr95ZZFN4-VZPJn8YBz718i3ZlmrnJhxe1Ekbf3lJ8bJ_3Pdr5Ot2menu5WS3SAbJrtJhrt0rsvsRVqxYVNw_ym40zStshdHc5pbmuWZG1dliEeaokoV-anBNPYCGuDhHjrB1BiajPLpfHmLDC9kJrdJC0Zi7hLK4pSxMLQJoCIPuIh5FAvwjiOAXN9Y3yHtRkSUrgncsY7IREEghzKlUKYUypTymPKkQ56tOkwr7pI_N-2hzK2aIel4-Uc-O1E1hikYtuEe6DbXEUdWIxgtS8BI-AbLBhiHPAaJVWM9Kvvj9SRX45mC0GygIl9ICMcdstPImarhcq7Ohcwhj1a3Aejw61WcmXxRtoHYFqJlWIg7lfyvhgtRgfC4FA6Ra5qxNp_1O9notCRTl37AItF1yPOVDv1rsbb_PoWH5DJoiHo7ODy4R65itypBdoe0itnC3Acntkge1GhByceLVpTvU5OvJA
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6V9AAXHuJlWtCCOMDBqWPvy8eAqAqHigOR2tNqnzSNa1uJI9T-embXTkR4CMHBsmWPrd2d2dlv7PE3CL12XnCjLU259yS8rRLBD9KUcEKsEhBw2Mj2ecpOZuTTGT3bQ2LzL0xIq7wMxXibqruKX_LXbdUoe9Raf3TZdlegVgh4QhIQH8O5W2ifUUDhI7Q_O_08PY-15ESRchHpModjQntWH_DYeXzKODwlspvynQUp8vbDMlMv_e8g56-Zk7fXdauuv6mq-mFZOr6Hzjcd6rNRFuN1p8fm5ieux__p8X10d8CqeNob1wO05-qHaDbFKxOz9nDPAo0B9mKAkdj2WXvzFW48rps6VX353bnBwZS65sKF9O0OBMJPLbgKKSFYz5t2df0IzY4_fHl_kg61GVJDBe9SRqkVbuI5bNYZosuJK83EqEwrZkWhcl0IVhinS--9ARwHLjnXWaCzs9z64jEaQUvcU4QLZSFOFl6DNyCUMEVKxQAVluBqcufzBI03CpJmIC4P9TMqCQFM0KgMoyTDKMmskBlP0JvtDW3P2fFn0XdB41uxQLYdT4Ae5DB3JTTbkQxsmpiSBDYfaG2hwTnmLtDluwS9AnuRCzOP94f910YulhJCko-yzBmHMDRBhxtzkoObWEmAU1QIUTKRoJfbyzDBw1cbVbtmHWUgpoMoEQbiSW992-YCGmYZ4SxBfMcud_qze6WeX0QScZ7TomSTBL3dWvDfBuvZP8geoDu92YbU0EM06pZr9xzgW6dfDDP1OxRPQ1E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+scoring+system+for+the+diagnosis+of+non-alcoholic+steatohepatitis+from+liver+biopsy&rft.jtitle=Journal+of+pathology+and+translational+medicine&rft.au=%EC%9D%B4%EA%B2%BD%EB%B6%84&rft.au=%EC%A0%95%EC%9D%80%EC%84%A0&rft.au=%EC%9C%A0%EC%9D%80%EC%8B%A4&rft.au=%EA%B0%95%EC%9C%A4%EA%B2%BD&rft.date=2020-05-01&rft.pub=%EB%8C%80%ED%95%9C%EB%B3%91%EB%A6%AC%ED%95%99%ED%9A%8C&rft.issn=2383-7837&rft.eissn=2383-7845&rft.spage=228&rft.epage=236&rft_id=info:doi/10.4132%2Fjptm.2020.03.07&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9267149
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2383-7837&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2383-7837&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2383-7837&client=summon